(Q43709237)

English

Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability

scientific article

Statements

Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability (English)
1 August 2001
573-579

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit